KR870700024A - 약, 비타민 또는 왁진의 근육내 주사용 제제 - Google Patents

약, 비타민 또는 왁진의 근육내 주사용 제제

Info

Publication number
KR870700024A
KR870700024A KR1019860700540A KR860700540A KR870700024A KR 870700024 A KR870700024 A KR 870700024A KR 1019860700540 A KR1019860700540 A KR 1019860700540A KR 860700540 A KR860700540 A KR 860700540A KR 870700024 A KR870700024 A KR 870700024A
Authority
KR
South Korea
Prior art keywords
salts
racemic
type
glucoheptonate
solution
Prior art date
Application number
KR1019860700540A
Other languages
English (en)
Inventor
파루크 닥터 핫지젤리모빅
Original Assignee
원본미기재
메파 악티엔 게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 메파 악티엔 게젤샤프트 filed Critical 원본미기재
Publication of KR870700024A publication Critical patent/KR870700024A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Abstract

내용 없음.

Description

약, 비타민 또는 왁진의 근육내 주사용 제제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (8)

  1. 유기 또는 무기산의 수용성 칼슘염, 특히 라세미형태, D-형 또는 L-형의 Ca 글루코헵토네이트를 함유하는, 약, 비타민, 또는 왁진의 근육내 주사용 제제.
  2. 유기 또는 무기산의 수용성 Ca 염, 특히 라세미형태, D-형 또는 L형의 Ca 글루코헵토네이트를 근육내 무통(無痛)주사에 의해 투여할 수 있는 제제를 만들기 위해 사용하는 용도.
  3. 제1항 또는 2항에 있어서 Ca염으로서 황산칼슘, 락토비온산, 레블린산 또는 락트산의 Ca 염, 또는 특히 레세미형태, D-형 또는 L-형의 Ca 글루코헵토네이트를 개별적으로 또는 혼합물로서, 약, 비타민 도는 왁진에 가하여 혼합한 제제.
  4. 제1항 내지 3항중 어느 하나에 있어서, Ca염을 증류 또는 2차 증류시킨 H2O, 생리염용액 또는 5% 글르코스 용액에 용해시킨 용액으로서 약에 가한 제제.
  5. 제1항 내지 4항중 어느 하나에 있어서, Ca염을 0.01~25%, 특히 10%의 용매내 농도로써 사용한 제제.
  6. 제5항에 있어서, 라세미형태, D-형 또는 L-형인 Ca 글루코헵토네이트 수용액을 사용한 제제.
  7. 제1항 내기 6항중 어느 하나에 있어서 300,000I.U. 의 페니실린에 대하여 0.5~2.5ml, 특히 1~1.5ml의 10% Ca 염용액을 가한 제제.
  8. 제7항에 있어서, 라세미형태 D-형, 또는 L-형의 Ca 글루코헵토네이트 용액 1~1.5ml를 가한 제제
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019860700540A 1984-07-12 1985-12-06 약, 비타민 또는 왁진의 근육내 주사용 제제 KR870700024A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH5860/84-9 1984-07-12
CH586084 1984-12-07
PCT/CH1985/000172 WO1986003413A1 (en) 1984-12-07 1985-12-06 Preparations for the intramuscular injection of drugs, vitamins or vaccines

Publications (1)

Publication Number Publication Date
KR870700024A true KR870700024A (ko) 1987-02-28

Family

ID=4300514

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860700540A KR870700024A (ko) 1984-07-12 1985-12-06 약, 비타민 또는 왁진의 근육내 주사용 제제

Country Status (9)

Country Link
EP (1) EP0204737B1 (ko)
KR (1) KR870700024A (ko)
AT (1) ATE74523T1 (ko)
AU (1) AU5198686A (ko)
DE (1) DE3585835D1 (ko)
DK (1) DK365786D0 (ko)
FI (1) FI863192A (ko)
NO (1) NO863082D0 (ko)
WO (1) WO1986003413A1 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267962B1 (en) 1990-12-21 2001-07-31 C-P Technology Limited Partnership Compositions and methods of treatment using peat derivatives
US5221254A (en) * 1991-04-02 1993-06-22 Alza Corporation Method for reducing sensation in iontophoretic drug delivery
NO20014746D0 (no) 2001-09-28 2001-09-28 Clas M Kjoelberg Smertelindrende middel
GB0218821D0 (en) * 2002-08-13 2002-09-18 Glaxosmithkline Biolog Sa Novel compositions
WO2006012700A1 (en) * 2004-08-04 2006-02-09 Team Health Pty Ltd Method of treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1023821A (fr) * 1950-04-21 1953-03-24 Solution stable de gluconate de calcium et procédé pour sa préparation
DE1007022B (de) * 1953-06-02 1957-04-25 Sandoz Ag Verfahren zur Verbesserung der Haltbarkeit und Loeslichkeit von Antihistamin-Praeparaten
DE1062389B (de) * 1958-02-11 1959-07-30 Wander Ag Dr A Verfahren zur Herstellung von sterilen, Kalziumsalze enthaltenden Vitamin-D-Loesungen
US4081527A (en) * 1976-12-07 1978-03-28 Pfizer Inc. Chlortetracycline compositions

Also Published As

Publication number Publication date
DE3585835D1 (de) 1992-05-14
FI863192A0 (fi) 1986-08-05
EP0204737B1 (de) 1992-04-08
WO1986003413A1 (en) 1986-06-19
AU5198686A (en) 1986-07-01
EP0204737A1 (de) 1986-12-17
NO863082L (no) 1986-07-30
DK365786A (da) 1986-07-31
DK365786D0 (da) 1986-07-31
ATE74523T1 (de) 1992-04-15
FI863192A (fi) 1986-08-05
NO863082D0 (no) 1986-07-30

Similar Documents

Publication Publication Date Title
US4153689A (en) Stable insulin preparation for nasal administration
CA2090422C (en) Pharmaceutical composition of florfenicol
EP0072462B1 (en) Pharmaceutical preparations
ATE64297T1 (de) Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung.
KR960000923A (ko) 단량체성 인슐린 유사체의 제제
ES2171469T3 (es) Composicion administrada por via nasal y preparacion que la contiene.
ATE16191T1 (de) Stabile salze von s-adenosinylmethionin, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen welche als aktive substanz diese derivate enthalten.
KR910000703A (ko) 테트라졸 자극성 아미노산 수용체의 길항물질
DE58901002D1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
US4777047A (en) Transdermal application form of calcium antagonists
KR830002510A (ko) 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물
KR870700024A (ko) 약, 비타민 또는 왁진의 근육내 주사용 제제
KR880007060A (ko) 제약 조성물
ES2052000T3 (es) Procedimiento para preparar composiciones farmaceuticas que contienen pentamidina.
BR0013283A (pt) Agente farmacêutico que compreende um derivado de benzamida como ingrediente ativo
US4476115A (en) Analgesic composition and method of treating subdermal pain
KR910002451A (ko) 메탄디포스폰산 유도체를 함유하는 국소투여용 약제 및 이의 용도
JPH03120230A (ja) 薬効成分の経皮吸収促進剤及び経皮吸収型製剤
US4666926A (en) Transdermal formulations
Newmark et al. Coumermycin a1—biopharmaceutical studies I
KR880012518A (ko) 나프탈-아세트산 유도체를 함유하는 진통 및 소염제약 조성물
KR880009943A (ko) 피리다지논 유도체
KR870001144A (ko) Nn-디메틸에틸옥사이드가 함유된 약제조성물 및 그의 생산방법
EP0003382A1 (en) Solvent vehicle for therapeutics and pharmaceutical composition containing it
RU2238086C2 (ru) Новая лекарственная форма n-(4-нитро-2-феноксифенил) метансульфонамида, способ ее получения и применения

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid